Detalhe da pesquisa
1.
A reply to "TCR+/BCR+ dual-expressing cells and their associated public BCR clonotype are not enriched in type 1 diabetes".
Cell
; 184(3): 840-843, 2021 02 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33545037
2.
A Public BCR Present in a Unique Dual-Receptor-Expressing Lymphocyte from Type 1 Diabetes Patients Encodes a Potent T Cell Autoantigen.
Cell
; 177(6): 1583-1599.e16, 2019 05 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-31150624
3.
IL-17 and limits of success.
Cell Immunol
; 339: 33-40, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30765202
4.
Once-weekly TransCon CNP (navepegritide) in children with achondroplasia (ACcomplisH): a phase 2, multicentre, randomised, double-blind, placebo-controlled, dose-escalation trial.
EClinicalMedicine
; 65: 102258, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37823031
5.
Current understandings of the pathogenesis of type 1 diabetes: Genetics to environment.
World J Diabetes
; 11(1): 13-25, 2020 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31938470
6.
Editorial: Ying and Yang Members of the Tumor Necrosis Factor Superfamily: Friends or Foes in Immune-Mediated Diseases and Cancer.
Front Immunol
; 8: 1584, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29218044